Last reviewed · How we verify

NCT07482410

Combined Effects of Feldenkrais Exercises and Active Release Exercises in Patients With Knee Osteoarthritis.

Active, enrolled NA Last updated 19 March 2026
What this trial tests

NA trial testing Active release and feldenkrais exercises along with standard physical therapy. in Knee Osteoarthritis in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 February 2025
Primary endpoint
15 March 2026
15 March 2026

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date15 February 2025
Primary completion15 March 2026
Estimated completion15 March 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 40 to 60, any sex, with Knee Osteoarthritis or Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Knee osteoarthritis is similarly to the arthritis of the hip which is due to the degeneration of the cartilagre due to wear and tear forces on the knee joint. The aim of the study is to investigate the combined effects of active release and feldenkrais exercises on pain, range of motion and functional disability of patients with knee osteoarthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07482410.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing